RADIOSENSITISING AGENT FOR CURING ONCOLOGICAL DISEASES

摘要

The invention relates to medicine. The inventive radiosensitising agent for curing oncological diseases comprises 8 bromine-caffeine, polyoxyethylene-sorbitan-monooleate, or polyoxyethylene-sorbitan-stearate, or polyoxyethylene-sorbitan-monolaurate, or polyoxyethylene-sorbitan-monopalminate, or polyoxyethylene-sorbitan-monostearate, or polyoxyethylene-sorbitan tristearate, methylcellulose, calcium or magnesium stearate and starch, with the following proportion of the ingredients: 75 - 968 mass %: bromine-caffeine, 0.5 2 mass % methylcellulose, 0.5 1 mass % calcium or magnesium stearate, 2.5 20 mass % starch, 0.5 2 mass % polyoxyethylene-sorbitan-monooleate, or polyoxyethylene-sorbitane-stearate, or polyoxyethylene-sorbitan-monolaurate, or polyoxyethylene-sorbitan-monopalminate, or polyoxyethylene-sorbitan-monostearate, or polyoxyethylene-sorbitane tristearate.